Page last updated: 2024-09-03

rc 3095 and Colorectal Cancer

rc 3095 has been researched along with Colorectal Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dal Pizzol, F; Di Leone, LP; Roesler, R; Schwartsmann, G1

Other Studies

1 other study(ies) available for rc 3095 and Colorectal Cancer

ArticleYear
MAPK pathway activation in colorectal cancer: a therapeutic opportunity for GRP receptor antagonists.
    The Lancet. Oncology, 2005, Volume: 6, Issue:7

    Topics: Animals; Antineoplastic Agents; Bombesin; Colorectal Neoplasms; Drug Delivery Systems; Humans; MAP Kinase Signaling System; Peptide Fragments; Rats; Receptors, Bombesin

2005